Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laynie Dratch

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Brain Communications|November 11, 2025
Cumulative incidence of motor and cognitive features in the amyotrophic lateral sclerosis-frontotemporal degeneration spectrumBarbara E Spencer, Sharon X Xie, Daniel T Ohm, et al.
Acta Neuropathologica|September 6, 2022
Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degenerationLucia A A Giannini, Daniel T Ohm, Annemieke J M Rozemuller, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
Higher neighborhood deprivation is associated with accelerated disease progression in behavioral-variant frontotemporal degenerationRory Boyle, Nadia Dehghani, Sheina Emrani, et al.
Alzheimer'S & Dementia. Behavior & Socioeconomics of Aging|December 5, 2025
Higher neighborhood deprivation is associated with accelerated disease progression in behavioral-variant frontotemporal degenerationRory Boyle, Nadia Dehghani, Sheina Emrani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2024
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTDMichael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, et al.
Annals of Neurology|July 25, 2022
Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral SclerosisKatheryn A Q Cousins, Leslie M Shaw, Sanjana Shellikeri, et al.
Neurology|January 2, 2024
Changes in Digital Speech Measures in Asymptomatic Carriers of Pathogenic Variants Associated With Frontotemporal DegenerationNaomi Nevler, Sunghye Cho, Katheryn A Q Cousins, et al.
Neurology|March 6, 2024
Disparities in Genetic Testing for Neurologic DisordersAaron Baldwin, Juliette Copeland, Meron Azage, et al.
Journal of Neurology|October 27, 2023
Genetic testing in adults with neurologic disorders: indications, approach, and clinical impactsLaynie Dratch, Meron Azage, Aaron Baldwin, et al.
Nature Reviews. Neurology|May 20, 2024
The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biologyMichael Benatar, Joanne Wuu, Edward D Huey, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Brain Communications|November 11, 2025
Cumulative incidence of motor and cognitive features in the amyotrophic lateral sclerosis-frontotemporal degeneration spectrumBarbara E Spencer, Sharon X Xie, Daniel T Ohm, et al.
Acta Neuropathologica|September 6, 2022
Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degenerationLucia A A Giannini, Daniel T Ohm, Annemieke J M Rozemuller, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
Higher neighborhood deprivation is associated with accelerated disease progression in behavioral-variant frontotemporal degenerationRory Boyle, Nadia Dehghani, Sheina Emrani, et al.
Alzheimer'S & Dementia. Behavior & Socioeconomics of Aging|December 5, 2025
Higher neighborhood deprivation is associated with accelerated disease progression in behavioral-variant frontotemporal degenerationRory Boyle, Nadia Dehghani, Sheina Emrani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2024
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTDMichael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, et al.
Annals of Neurology|July 25, 2022
Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral SclerosisKatheryn A Q Cousins, Leslie M Shaw, Sanjana Shellikeri, et al.
Neurology|January 2, 2024
Changes in Digital Speech Measures in Asymptomatic Carriers of Pathogenic Variants Associated With Frontotemporal DegenerationNaomi Nevler, Sunghye Cho, Katheryn A Q Cousins, et al.
Neurology|March 6, 2024
Disparities in Genetic Testing for Neurologic DisordersAaron Baldwin, Juliette Copeland, Meron Azage, et al.
Journal of Neurology|October 27, 2023
Genetic testing in adults with neurologic disorders: indications, approach, and clinical impactsLaynie Dratch, Meron Azage, Aaron Baldwin, et al.
Nature Reviews. Neurology|May 20, 2024
The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biologyMichael Benatar, Joanne Wuu, Edward D Huey, et al.
Pageof 4